Delivery Order SPE2DR25D2018-SPE2DR26FZ1C2
Award Date 2/3/26
Potential Completion Date 2/4/26
Potential Value $8.8K
Federal Agency
Awardee
Ultimate Awardee
PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Defense Logistics Agency awarded a delivery order valued at $8,519.29 to AmerisourceBergen Drug Corp for ENBREL 50 mg/ml SureClick auto-injectors, with performance in Conshohocken, Pennsylvania and completion by January 16, 2026. This non-set-aside, competitively awarded contract uses firm fixed pricing and represents a single delivery order under AmerisourceBergen's larger indefinite delivery contract with DLA Troop Support Medical. ENBREL is a biologic immunosuppressant used to treat...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $9,253.56 to AmerisourceBergen Drug Corp for ENBREL 50 mg/mL SureClick auto-injectors, with an ultimate completion date of May 21, 2025. This non-set-aside, competitively awarded contract utilizes firm fixed pricing and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. ENBREL is a biologic immunosuppressant medication commonly used to treat rheumatoid arthritis and other...
- The Defense Logistics Agency awarded a delivery order valued at $8,008.37 to AmerisourceBergen Drug Corp for ENBREL 50 MG/ML SureClick auto-injectors, with performance completed by July 29, 2025. This non-set-aside, competitively awarded contract utilizes firm fixed pricing and will be performed at the contractor's corporate headquarters in Conshohocken, Pennsylvania. ENBREL is a biologic immunosuppressant medication used to treat rheumatoid arthritis and other autoimmune conditions,...
- The Defense Logistics Agency awarded a delivery order valued at $18,617.73 to AmerisourceBergen Drug Corp for ENBREL 50 MG/ML SureClick auto-injectors, with completion scheduled for October 31, 2025. This non-set-aside, competitively awarded contract utilizes firm fixed pricing and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. ENBREL is a biologic immunosuppressant used to treat rheumatoid arthritis and other inflammatory conditions, making this...
- The Defense Logistics Agency (DLA) awarded AmerisourceBergen Drug Corp a delivery order valued at $10,276.74 for ENBREL 50 mg/mL SureClick auto-injectors on September 4, 2025, with completion scheduled for September 5, 2025. This competitively awarded, firm fixed-price contract carries no set-aside designation and will be performed at AmerisourceBergen's corporate headquarters in Conshohocken, Pennsylvania. ENBREL is a biologic immunosuppressant used to treat rheumatoid arthritis, psoriasis, and...
- The Defense Logistics Agency awarded a delivery order valued at $31,767.63 to AmerisourceBergen Drug Corp for ENBREL 50 MG/ML SureClick auto-injectors, with an ultimate completion date of October 15, 2025. This is a firm fixed price, competitively awarded contract with no set-aside designation. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, will perform the work at its corporate office location. The delivery order falls under...
- The Defense Logistics Agency awarded a delivery order valued at $81,631.30 to AmerisourceBergen Drug Corp for ENBREL 50 MG/ML SureClick auto-injectors, with an ultimate completion date of August 7, 2025. This is a firm fixed-price delivery order with no set-aside designation, executed through competitive procedures. The product will be delivered to AmerisourceBergen's facility in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's broader Indefinite Delivery...
- The Defense Logistics Agency awarded a delivery order valued at $61,490.24 to AmerisourceBergen Drug Corp for ENBREL 50 mg/mL SureClick auto-injectors, with an ultimate completion date of August 13, 2025. This competitively awarded, firm fixed-price contract contains no set-aside designation and will be performed at the vendor's Conshohocken, Pennsylvania location. ENBREL is a biologic medication used to treat rheumatoid arthritis and other autoimmune conditions and is commonly stocked within...
- The Defense Logistics Agency awarded a delivery order valued at $10,378.60 to AmerisourceBergen Drug Corp for ENBREL 50 mg/ml SureClick auto-injectors on November 10, 2025, with completion scheduled for November 12, 2025. This firm fixed-price delivery order was competitively awarded with no set-aside designation and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. ENBREL is a biologic immunosuppressant used to treat rheumatoid arthritis and other...
- The Defense Logistics Agency awarded a $259,099.12 delivery order to AmerisourceBergen Drug Corp for ENBREL 50 mg/ml SureClick auto-injectors, with an ultimate completion date of September 18, 2025. This is a firm fixed-price, competitively awarded contract with no set-aside designation. The order will be fulfilled from AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, where the company maintains its primary pharmaceutical distribution operations. ENBREL is a...